AI assistant
Sending…
Brainsway Ltd. — Earnings Release 2021
May 20, 2021
6701_rns_2021-05-20_6ff07a5a-0744-4026-b8d4-7053ecd54dc3.htm
Earnings Release
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights false
| ���������� ��"� | 2 380 |
| BRAINSWAY LTD | |
| Corporation no: 513890764 | 10767 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 19/05/2021 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2021-02-086961 | Time of broadcast: 19:59 19:59 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onBrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
BrainsWay_Reports_First_Quarter_2021_Financial_Results_and_Operational_Highlights_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: BWAY | Date of revision of form structure: 04/05/2021 |
| Address: ����� 19 , ������� 91451 , Tel: 02-5813140 , Fax: 02-5812517 | |
| E-mail address: [email protected] Company site: www.Brainsway.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: | |
| Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: [email protected] 1 | |
More from Brainsway Ltd.
Regulatory Filings
2026
Apr 21
Report Publication Announcement
2026
Apr 21
Regulatory Filings
2026
Apr 21
Transaction in Own Shares
2026
Apr 21
Regulatory Filings
2026
Apr 21
Report Publication Announcement
2026
Apr 21
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Report Publication Announcement
2026
Mar 26
Capital/Financing Update
2026
Mar 26